Context. The aim of palliative care is to improve quality of life for patients with serious illnesses by treating their symptoms and adverse effects. Hospice care also aims for this for patients with a life expectancy of six months or less. When conventional therapies do not provide adequate symptom management or produce their own adverse effects, patients, families and caregivers may prefer complementary or alternative approaches in their care. Objectives. To evaluate the available evidence on the use of complementary or alternative medicine (CAM) in hospice and palliative care and to summarize their potential benefits. Methods. A defined search strategy was used in reviewing literature from major databases. Searches were conducted using base terms and the symptom in question. Symptoms included anxiety, pain, dyspnea, cough, fatigue, insomnia, nausea, and vomiting. Studies were selected for further evaluation based on relevancy and study type. References of systematic reviews were also assessed. After evaluation using quality assessment tools, findings were summarized and the review was structured based on PRISMA guidelines. Results. Out of 4682 studies, 17 were identified for further evaluation. Therapies included acupressure, acupuncture, aromatherapy massage, breathing, hypnotherapy, massage, meditation, music therapy, reflexology, and reiki. Many studies demonstrated a short-term benefit in symptom improvement from baseline with CAM, although a significant benefit was not found between groups. Conclusion. CAM may provide a limited short-term benefit in patients with symptom burden. Additional studies are needed to clarify the potential value of CAM in the hospice or palliative setting.
Introduction
About one-third of American adults have reported use of complementary and alternative medicine (CAM) including mind and body practices, among many others. 1, 2 Despite increasing use, and many CAM therapies lack sufficient, high quality evidence to support their use in the prevention and treatment of diverse conditions. 3 In addition, many health care professionals continue to have inadequate knowledge about CAM therapies.
CAM therapies have been used in the palliative care and hospice settings for many years, especially in the United Kingdom. Patients in these settings commonly report a high symptom burden potentially affecting their quality of life. Distressing symptoms may be related both to the underlying disease, as well as adverse effects from treatment. As a result, when conventional therapies do not provide adequate symptom relief or produce additional adverse effects, patients, families, and caregivers may select CAM approaches, especially near the end of life.
Data from the 2007 National Home and Hospice Care Survey revealed that CAM was offered by over 40% of hospice care providers.
About one-quarter of the surveyed patients received some form of a CAM therapy during hospice care. The therapies most commonly offered by hospice care providers included massage, supportive group therapy, and music therapy. 4 The Hospice and Palliative Nurses Association (HPNA) has also recognized the prevalence and potential role of CAM in the palliative and hospice setting. The HPNA encourages the use of licensed and/or certified CAM services to provide holistic end-of-life care. 5 With increasing support for CAM, the need for more data on different practices has continued to grow.
A 2000 systematic review assessed the effectiveness of CAM therapies on selected symptoms at end of life. The authors identified that acupuncture and massage, among others, may provide pain relief while patients with end stage chronic obstructive lung disease may have less dyspnea from using acupressure and muscle relaxation. 6 In the almost 20 years intervening, additional studies assessing the potential role of CAM therapies at the end of life have been published. The purpose of this systematic review was to identify and evaluate new evidence of CAM therapies in managing common symptoms and improving quality of life in the palliative and hospice setting.
Methods

Protocol and Registration
The systematic review was conducted in accordance to the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) statement and is registered in the International Prospective Register of Systematic Review (PROSPERO): CRD42017067375.
7,8
Literature Search
A literature search was conducted in four databases including MEDLINE through PubMed, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, and Embase, for studies which assessed the efficacy of a CAM therapy in a palliative or hospice setting. The initial search was focused on the common symptoms that patients would experience in this setting.
Specific terms were used according to the database's preferred terminology. Medical subject headings (MesH) terms, headings, thesaurus terms, and Emtree terms were used for PubMed, CINAHL, PsycINFO, and Embase, respectively. The search consisted of three base terms, "complementary medicine", "palliative care", "hospice care", and a specific symptom as a fourth term. "Complementary" was the preferred MeSH term in PubMed while "alternative" was preferred for Embase, PsycINFO, and CINAHL. Symptoms included "pain", "nausea", "vomiting", "anxiety", "cough", "fatigue", "insomnia", and "dyspnea". All are commonly reported by patients receiving palliative care, with the majority of patients diagnosed with cancer. 6, 9 Filters for study types, date range of January 1999 to May 2016, and English language were applied after entering search terms to narrow results.
A second search focused on CAM and quality of life at end of life was also conducted to include multiple symptoms and overall aspects of a patient's life. In this search, the same initial base terms, "complementary medicine", "palliative care", "hospice care", were used and the fourth term was "quality of life". Table 1 provides an overview of the specific terms used and filters applied according to database.
A third search was conducted using the same search terms and filters for date range and English language. However, rather than filter for controlled trials, a filter for systematic reviews was applied.
Eligibility
Each author screened results from one assigned database based on title and abstract. To be eligible for review, controlled trials had to assess the efficacy of a CAM therapy in managing a symptom or quality of life in patients in a palliative or hospice setting. Systematic reviews were screened using the same eligibility criteria. Once systematic reviews were identified, their references were screened for additional controlled trials and systematic reviews that met the inclusion criteria. References of these additional sources were also screened. Meeting abstracts and quasi-experimental studies were excluded and duplicates were also removed.
Study Selection, Data Extraction, and Analysis
After compiling the full-text articles, all authors independently assessed and scored them using the Jadad scale for controlled trials. Randomization, blinding, and accountability for study participants are all factors assessed in the Jadad scale, and account for selection bias, performance and detection bias, and attrition bias, respectively. 10 Studies which received a Jadad score of three or greater were included.
A meeting of the four authors was held to review Jadad scores. Disagreements were resolved by discussion of the studies and a consensus was subsequently reached. After finalizing selected articles, each author independently extracted the data which was subsequently verified by the other three authors. The study design, patient population, CAM intervention, duration of therapy, symptom(s) assessed, outcomes, measurement tools, and results were assessed.
Of the 3705 unique records identified and screened, 86 full-text articles were analyzed in depth. Of these, 69 were excluded for reasons such as inappropriate study population, resulting in 17 eligible for inclusion ( Figure 1 ). Table 2 summarizes findings from the 17 included studies of CAM interventions in the palliative or hospice care setting. The studies which met our inclusion criteria assessed mind and body interventions.
Results
Symptoms assessed included pain, nausea and vomiting, dyspnea, anxiety and depression, and quality of life.
Many studies tested for improvement in multiple symptoms, with pain most frequently assessed (n=8).
Sixteen trials enrolled patients with advanced cancer with a few including patients with other diseases and one enrolling patients with HIV/AIDS. The visual analogue scale (VAS) and Rotterdam Symptom Checklist (RSCL) were the most commonly used measurement tools. Assessment tools are described in Supplemental Table 1 .
Acupressure
One study assessed the efficacy of acupressure versus sham wristbands in reducing nausea and vomiting for three days. 11 Measurements were recorded every 6 hours while wearing the wristbands. One patient reported mild swelling as an adverse event. Antiemetics were continued for participants, although the specific drug and administration time were not documented. The study was a pilot study and evidence of a difference between study groups was unlikely. The investigators suggested acupressure may be considered as an adjunct for palliative care patients in controlling nausea and vomiting.
Acupuncture
A pilot study evaluated the efficacy of electroacupuncture versus a palliative care nurse-led supportive care group for multiple symptoms based on the Edmonton Symptom Assessment Scale (ESAS). 12 Acupuncture points were chosen based on specific symptoms of each patient. The supportive group involved a 20 to 30-minute meeting with a palliative care nurse who provided counseling, emotional support, and coping strategies.
Scores were recorded before and immediately after each intervention, and during weekly follow-ups.
Acupuncture improved symptoms immediately after each session. yet ESAS scores increased by the 6-week follow-up. Right-leg stiffness and a "falling asleep" sensation were the only reported adverse effects. Nurse-led supportive care improved symptom scores and benefit was seen at 6-week follow-up. Acupuncture may be feasible as a treatment for symptom reduction with immediate effects; however, its long-term benefits are uncertain.
Breathing
A study compared the efficacy of one versus three sessions of a complex breathing intervention. 13 Participants reported a heavy breathlessness burden, defined by at least a score of 3 out of 10 on the Numerical Rating Scale (NRS). The group receiving three sessions had a worse baseline score in the mastery domain of the Chronic Respiratory Questionnaire -Self-Administered Survey (CRQ-SAS) while the other group had a worse baseline for anxiety. Breathing techniques included breathing training, anxiety management, relaxation, and pacing or prioritization. Secondary measures included variations of breathlessness reporting such as "average intensity", "distress", and "coping" using the NRS, CRQ-SAS, and HADS. A clinically significant improvement for worst breathlessness was seen; however, a "usual care" control arm was not included as a comparison for the intervention. The trial was well structured and replicable, which could warrant larger future studies.
Hypnotherapy
Two studies assessed hypnotherapy in the palliative care and hospice setting. A crossover study compared hypnotherapy to standard care on pain measures. 14 In addition to hypnotherapy sessions, participants were taught self-hypnosis to use between treatment sessions. Symptoms were rated using the MYMOP Version 2 (MYMOP2) tool at baseline, week 4, and week 8. In addition to pain, effects on anxiety, insomnia, depression, headache, and desire to stop smoking were assessed. No study personnel confirmed the usage of proper technique or adherence to the assigned self-hypnosis, allowing for questions of the quality of the intervention. Because patients chose their most burdensome symptoms, multiple symptoms were evaluated; therefore, identifying the specific symptom(s) that hypnotherapy affects may be difficult.
A second study compared the effects of hypnotherapy to standard care on quality of life, anxiety, and depression. 15 Patients rated their symptoms on their first visit and upon completion of the intervention. Missing RSCL subscale values were substituted using the personal scale mean of the respective respondent if at least 50% of the items on the subscale were completed. Substituting incomplete data would affect the results and the true efficacy of the intervention would be unclear. Symptom management was conducted with medications and was not evaluated in depth. Therefore, the effect of hypnosis versus medications on symptoms remains unclear.
Benefit was noted in the hypnosis group and supportive group which suggests that some form of cognitive intervention may assist patients at end of life with coping.
Massage Therapy Alone
Seven studies have evaluated the efficacy of massage therapy; three were of massage therapy alone, three of massage combined with aromatherapy, and one assessed massage in combination with meditation.
One study recruited 509 patients with 380 randomized to six 30-minute individualized massage sessions by a licensed massage therapist or simple touch. 16 A similar proportion of patients in both groups previously received massage therapy; baseline pain scores were also similar between groups. Secondary measurements include the MPAC mood scale and the McGill Quality of Life Questionnaire. Scores were recorded at baseline, weeks 1 and 2, and 1.5 weeks after the intervention completion. Two serious adverse events were reported in the massage group (respiratory infection and gastrointestinal bleed), but were deemed unrelated to treatments.
No control group was included which would have assisted in differentiating a true benefit from massage therapy. The study is notable because of its large, multisite design and shows some statistically significant immediate benefits with massage therapy. The short study period may have accounted for failure to detect a significant difference in sustained, longer term scores.
A Spanish trial evaluated the effects of physical therapy, including massage and exercise, in patients with advanced cancer. 17 Of 92 patients screened for eligibility, 24 were enrolled; three quarters were men and half had lung cancer. The intervention group received six physiotherapy sessions which consisted of several massage techniques, mobilization, and local and global exercises performed by a therapist. Pre-and postintervention scores assessed changes in pain while the mood portion of the MPAC and the Memorial Symptom Assessment Scale (MSAS) evaluated mood. Only 15 patients were assessed in the final analysis. Multiple techniques were implemented in the massage group and no standardized protocol was available for the trial to be replicated. Techniques were chosen according to the type of cancer, which may warrant further study into specific massage techniques to provide optimal symptom control.
Another study compared a standardized massage or usual hospice care. 18 During enrollment, none of the participants reported receiving massage therapy. All staff were blinded to subject group assignment except for the person who received eligibility forms and a social worker who scheduled the massage therapists. Although a standardized protocol for massage was created, sessions were still individualized and the duration varied from 30 to 50 minutes. After the intervention, a few subjects reported receiving previous massage therapies prior to enrollment. Several subjects received additional massage sessions in between the study sessions. While the study did not report a significant difference with individuals receiving additional massages, the quality of the study intervention is questionable. The results may have been affected as a result of receiving more sessions and from an unknown source.
Massage and Aromatherapy
A single-blinded study evaluated the long-term benefits of aromatherapy massage with lavender oil versus massage with an inert oil versus no massage. 19 Enrollment fell short of the 15 patients needed in each study arm to detect a 2.3-point difference on the VAS. Six patients withdrew as a result of death or feeling unwell. Groups were similar at baseline except the massage only group had a significantly higher RSCL score.
Analyses were performed for the three study groups and an additional combined aromatherapy and massage group. The combined aromatherapy and massage group was not included as an initial study group to which participants were randomized. While not mentioned in the methodology section, results from the combined group were presented in the analysis; this is an important consideration when evaluating the analyses.
Another pilot study tested the feasibility of aromatherapy massage in patients with cancer. Of 46 patients recruited from a palliative day care center, 29 completed the trial. 20 The aromatherapy massage and control groups had similar mean performance status scores of 1.4 and 1.3, respectively. Six patients in the control group were taking antidepressants compared to none in the aromatherapy massage group. Adverse effects were limited to a rash following massage. A high withdrawal rate impacts assessment of the intervention and larger studies are needed.
Aromatherapy massage versus massage with an inert oil were compared for their effect on anxiety and quality of life. 21 At baseline, patients randomized to aromatherapy reported poorer quality of life compared with those in the massage group. Quality of life (QoL) was measured at baseline and one week after the last massage was administered. Anxiety scales were administered before and after each massage. Significantly greater improvement in RSCL subscales was noted for the aromatherapy group, despite a poorer baseline QoL. Further study into the specific essential oil used may be warranted to determine the impact on symptom improvement.
No entry criteria were required for the study and a control group was not used. The lack of a control group is important as each modality has yet to be proven beneficial as individual treatments.
Massage and Meditation
A study evaluated both meditation and massage for improving QoL near end of life. 22 A total of 106 patients were screened with 58 randomized to one of four groups. Despite randomization, baseline characteristics in the study groups varied. The standard care group had higher mean viral load while the combined meditation and massage group had the highest CD4 count. Differences in baseline characteristics could affect the results of the interventions depending on patient health status. Responses were recorded at baseline, at the end of weeks 2 and 4 during the intervention period, and 1-month after the intervention (week 8). The combined meditation and massage group demonstrated the greatest overall improvement even after multivariate adjustment for baseline differences. However, because the combined group had a higher CD4 count and a lower viral load at baseline, the results may reflect better participant disease control in comparison to the other groups.
Music Therapy
A palliative care team analyzed 198 patients with advanced, life-limiting illness. 23 The music therapy group received 20-minute music therapy sessions performed by a music therapist. Each music therapy session was individualized, although a standardized framework for the sessions was implemented. The control group received the same comfort measures as the music therapy group during the session; however, a music therapist was not present. Both groups had similar baseline characteristics. Pain was assessed at pre-and postintervention. Although 20 minutes was allotted, a few accounts of up to 50 minutes were noted. As a result, the timing of the post-intervention score also varied. Blinding was broken for a few patients because participants revealed their group assignment to the research assistant. Only immediate effects were studied, so the long-term benefits are unknown.
In an Australian study, 25 patients were recruited from inpatient hospice services. 24 Only age, sex, and diagnosis were reported for baseline characteristics. Music session length varied from 20-40 minutes and any sessions outside of the study's session duration were not included in the data. Therefore, data could be missing that would affect the overall results. Only pre-and post-intervention scores were recorded so only short-term effects were assessed. Patients in the control group continued to receive music therapy outside of the study, making it unclear if the control group was a true control with no pre-exposure to music therapy. Both studies showed music therapy improved symptom burden; participants requested and continued receiving music therapy outside of the studies.
Reflexology
Two studies assessed the efficacy of reflexology in improving QoL. One study randomized 12 patients receiving palliative care to receive reflexology or placebo. 25 Interventions were carried out on days 1, 3, and 5; assessments using the VAS were recorded at baseline and after the intervention. Multiple symptoms were assessed including appetite, breathing, communication, constipation, pain, and tiredness. Although the reflexologist could avoid reflexology points to simulate "placebo reflexology", some skill may still remain in providing patients relief through a foot massage. Overall, patients reported an improvement in QoL, but with the short duration and small population, the generalizability of the study to other care centers is difficult.
In the second trial, patients who were not receiving active cancer treatment were recruited to receive reflexology or foot massage. 26 Seventeen patients were included in the analysis. Participants and interviewers were blinded to the intervention. "Placebo" foot massage may have provided some level of relief for the patients. Neither group demonstrated significant improvement in mood and the study failed to demonstrate superiority of reflexology over foot massage. Foot discomfort was the predominant adverse effect, along with nausea, shaking, and sleep disturbances. Both studies used foot massage as a placebo", but the benefit of massage alone may have occurred.
Reiki
One trial assessed reiki for improvement in pain and QoL. 27 Of 73 patients screened for eligibility, 24were enrolled. Participants received varying amounts of opioids, but were all considered to be opioid tolerant as defined by having a dose increase of over 5% per day. Eleven patients were taking less than 60 mg of morphine per day, eight received between 60-300 mg/day and five were taking over 300 mg/day. Primary outcome measures were assessed on days 1 and 4. Quality of life was assessed using ESAS. The use of objective outcome measures could provide more evidence if a placebo effect was present. Although no difference was found between the two groups, the study was practical because it also assessed conventional treatment. Reiki as an adjunct to opioid therapy warrants further study with a larger cohort and longer study period.
Discussion
This systematic review of randomized controlled trials was conducted to evaluate the newer evidence available since the 2000 publication by Pan and colleagues. 6 The older databases, CancerLIT and AIDS-LINE, have since been incorporated into MEDLINE, resulting in fewer and more comprehensive databases from which our searches were conducted. No randomized controlled trials of herbal products or dietary supplements were identified in the literature search, resulting in the included studies evaluating mind and body CAM. Using the Jadad scale, we identified higher quality studies on CAM in the palliative or hospice setting.
Massage therapy, combined with aromatherapy, meditation, or massage alone, were the most common Our search terms included "palliative care" or "hospice care". While those enrolled in hospice care receive palliative care, not all patients receiving palliative care may be near end of life. A few studies included patients enrolled in palliative care only and no specifications were stated on whether patients were still receiving active treatment. Therefore, the characteristics of the patient population may vary and affect how patients may feel or perform overall.
The Jadad scale was used as the evaluation tool to decide which studies to include in the review. Despite the tool's simplicity, our authors' scores were inconsistent at times and differences were resolved through discussions involving all authors. The reasons for variability in Jadad scores included ambiguity of the studies and differing opinions. While all studies included scored a three or higher on the Jadad scale, many other characteristics differed between the articles. For example, one study enrolled a total of eight patients while another study enrolled 200 patients.
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Various study designs were used and what was considered "control" or "placebo" differed among the studies. Depending on what one considers as "CAM", the control group of a study may be considered another CAM. One such example is the reflexology study conducted by Hodgson et al in which the "placebo reflexology" was a gentle foot massage. 26 In addition, by the nature of mind and body CAM, true blinding of the participants and performers is difficult. Some methods have been developed to provide blinding of CAM such as sham acupuncture. However, sham acupuncture has mixed results on its reliability as a placebo. 28 We were unable to perform a meta-analysis as a result of the varying measurement tools used by the studies we evaluated. Additionally, the majority of measurement tools were subjective. A few studies used objective measurements, such as blood pressure or respiratory rate. 20 Not all studies performed statistical analyses and one study that did reported failure to account for multiple testing. 20 In addition, multiple studies assessed quality of life which encompasses multiple symptoms. As a result, determining what symptoms benefit most from a CAM intervention is difficult since multiple symptoms were evaluated simultaneously.
Enrollment rates for studies were low despite recruitment periods of a few years in several studies. 12 In addition, as a typical finding in the hospice care setting, many participants withdrew because of poor health or death. The high withdrawal rate further decreases the small population size and many studies were unable to provide power calculations to conclude any significance. Taking this into account, some studies had broader inclusion criteria to recruit as many participants as possible. However, in doing so, a diverse population in which treatments and demographic characteristics vary greatly among patients resulted. A few studies addressed concomitant use of drug therapy, but did not specify the drugs used or duration of drug therapy. 11, 13 Studies were conducted in multiple countries, such as the United Kingdom or Spain. 18, 21 The applicability of such studies should be taken into account as the patient population and treatment modalities may differ depending on the country. Baseline scores for patients' reported symptoms also differed between study groups in several studies, which could affect the results of how well the intervention managed the symptom(s) in question.
Although limitations are apparent, our review identified new studies which show a modest benefit in improvement of patients' quality of life and symptoms. Despite few studies reporting statistically significant changes in symptom improvement, clinically significant changes were documented and patients reported positive outcomes in interviews and on questionnaires. Adverse effects were uncommon and minor in nature. A professional in the specific CAM approach was recruited to perform the intervention in multiple studies. The expertise of the CAM provider is important to ensure the highest quality of CAM is given.
We identified common outcome measures which may be considered for future studies. A possible metaanalysis may be performed if new studies used the same measures. Our work has also identified barriers to CAM studies which may be taken into consideration, such the lack of a universal assessment tool or accepted placebo for proper assessment of a CAM. Small patient populations and short study periods are additional barriers to providing a higher quality study to demonstrate adequate power. A few studies simultaneously assessed multiple CAM modalities, making it difficult to identify which therapy provides more benefit. For patients who are interested in CAM, a discussion should be held with their healthcare providers about potential value and considerations.
Conclusions
Since 2000, additional studies evaluating CAM in the palliative and hospice setting have been published.
This systematic review identified and evaluated pilot studies testing the feasibility of a CAM intervention in the palliative or hospice setting as well as larger trials of a previously tested CAM. Of the studies reviewed, a modest short-term benefit was observed in some trials. Future studies should consider a multicenter design to recruit more patients. One CAM modality should be assessed at a time and a universal tool for evaluating symptom improvement should be established for consistency. Of the CAM interventions summarized, music therapy, massage therapy, and reiki had the most potential benefit although all studies had significant limitations. Continued research is essential to provide the best patient care in hospice and palliative care.
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